Pfizer's spinoff Zoetis pumping up global equine market; China's animal vaccine market poised for growth;

> Top animal health company Ceva has released its annual report, and it grew its presence considerably in both Greece and Turkey. Report

> A new report forecasts the global equine market until 2019, citing Zoetis ($ZTS), Merck ($MRK), Bayer, Lilly's ($LLY) Elanco and Boehringer Ingelheim's Vetmedica as the major companies keeping it thriving. Report

> A new market report says the Chinese animal vaccine market maintained a high growth rate of of 26.3% between 2004-2013 and forecasts it to grow even further by 2016. Release

> Cargill's animal nutrition business recalled its Nutrena Naturewise Meatbird Feed because it found the product had too much sodium in it. FDA notice

> A professor at Tufts has slammed food producers for using confined crates, saying some conditions are helping the spread of antibiotic-resistant infections, and urged the Massachusetts legislature to address the issue. Article

> Henry Schein, Inc. ($HSIC), which provides the most dental products to office-based animal health practitioners in the world, acquired 60% of of SmartPak, the largest provider of horse supplies and equine supplements in the U.S. More

Suggested Articles

Pfizer spinoff Zoetis met Q2 expectations and brightened its full-year forecast, but it's looking to M&A to drive further growth.

Fresenius’ new CEO has pulled off a dealmaking double play, committing more than $5.4 billion to expand its reach in both sterile generics and in biosimilars.

Bayer’s pharma products have been growing lickety-split, and its 2016 numbers show just how—and how much. But with the big Monsanto merger top of mind at Bayer…